We are live on ! Find out more
RLYB icon

Rallybio

47 hedge funds and large institutions have $20.9M invested in Rallybio in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1.25% less ownership

Funds ownership: 78.16% → 76.91% (-1.3%)

4% less funds holding

Funds holding: 49 → 47 (-2)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

73% less capital inflows, than outflows

Capital inflows: $131K | Capital outflows: $494K

Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
0.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
9
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RLYB Hedge Fund Activity: Q1 2025 in Review

47 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q1 2025, worth a combined $20.9M — down 33% from $31.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RLYB and 2 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 9 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $41.7K. The largest seller was Canaan Partners XI, cutting an estimated $130K.

  • 47 institutional investors held Rallybio (RLYB) as of Q1 2025, down from 49 in Q4 2024.
  • Funds reported $20.9M of Rallybio stock for Q1 2025, down 33% quarter-over-quarter.
  • 2 funds opened new Rallybio positions in Q1 2025 and 4 closed out, a net change of -2 holders.
  • The largest Rallybio buyer in Q1 2025 was Citadel Advisors, an estimated $41.7K added.
  • The largest Rallybio seller in Q1 2025 was Canaan Partners XI, an estimated $130K sold.

Based on aggregated 13F filings for Q1 2025.